Although bariatric surgery is becoming an increasingly accepted option to reverse type 2 diabetes, lifestyle interventions, including smoking cessation, improved nutrition, and increased physical activity, coupled with appropriate pharmacotherapy, remain the mainstays for the management of type 2 diabetes.
New data from phase III clinical trials of dexamethasone 0.7 mg intravitreal implant reaffirm that this novel pharmacotherapeutic intervention is well-tolerated and effectively improves vision in patients with macular edema secondary to a branch or central retinal vein occlusion.
A novel analytic model, the Markov model, allows ophthalmologists to gauge the probability of progression of glaucoma in their patients over time simply by knowing their current mean deviation value.
Selective laser trabeculoplasty (SLT) is effective in lowering IOP in patients with glaucoma, but in combination with certain topical therapies, SLT may be less effective in lowering IOP.